Jennifer Fernández Alarcón

Jennifer Fernández Alarcón serves as a Research Collaborator at IQS (Institut Químic de Sarrià), part of Universitat Ramon Llull's School of Engineering and Technology. Her work focuses on nanomedicine applications for cancer therapy and immunomodulation.

Her research interests prominently feature Nanoparticle Drug Delivery, Cancer Immunotherapy, and Macrophage Targeting, with specific expertise in glycoconjugate-functionalized gold nanoparticles. The fingerprint analysis reveals strong activity in Macrophage biology (100%), Nanoparticle pharmacology (86%), Neoplasm research (60%), and Gold Nanoparticle applications (50%).

Recent publications demonstrate consistent focus on therapeutic nanoparticle systems, particularly examining cellular uptake mechanisms, liver macrophage polarization, and cancer cell targeting. Her work bridges nanotechnology with immunology through innovative glycopeptide and diterpenoid modifications.

She actively participates in collaborative projects including TECARN (2024-2026), focused on mRNA analysis for vaccination. Her advising role includes supervision of multiple research outputs across nanomedicine and gene therapy domains.